Interim C-reactive protein levels predict the prognosis of patients with metastatic colorectal cancer receiving immunotherapy: a retrospective cohort study

Background: Serum C-reactive protein (CRP) level is frequently considered a prognostic predictor of immunotherapy. However, the prognostic role of the interim serum CRP levels before the third course of immunotherapy (CRP-C3) in patients with metastatic colorectal cancer (mCRC) receiving immunothera...

Full description

Saved in:
Bibliographic Details
Main Authors: Hai-Yan Fu, Yi-Yang Zhang, Jin-Shan Huang, Jin-Xin Hu, Kun-Hao Bai, Zhi-Qiang Wang
Format: Article
Language:English
Published: SAGE Publishing 2025-07-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359251356581
Tags: Add Tag
No Tags, Be the first to tag this record!